Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Change in Accured Expenses (2023 - 2025)

Guardian Pharmacy Services' Change in Accured Expenses history spans 3 years, with the latest figure at -$236000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 101.76% year-over-year to -$236000.0; the TTM value through Dec 2025 reached $1.3 million, up 143.07%, while the annual FY2025 figure was $1.3 million, 143.07% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$236000.0 at Guardian Pharmacy Services, down from $5.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $13.4 million in Q4 2024 and bottomed at -$20.7 million in Q3 2024.
  • The 3-year median for Change in Accured Expenses is $3.2 million (2024), against an average of $413333.3.
  • The largest annual shift saw Change in Accured Expenses skyrocketed 148.38% in 2024 before it crashed 1019.89% in 2025.
  • A 3-year view of Change in Accured Expenses shows it stood at $5.4 million in 2023, then skyrocketed by 148.38% to $13.4 million in 2024, then tumbled by 101.76% to -$236000.0 in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Change in Accured Expenses are -$236000.0 (Q4 2025), $5.6 million (Q3 2025), and -$9.9 million (Q2 2025).